← Company directoryNASDAQ · SEC EDGAR

Myriad Genetics, Inc.

MYGN

A primary-source company identity page built for fast discovery, filing verification and consistent financial research.

SHARE PRICE · INDICATIVE——

A recent price could not be verified. Check the exchange before trading.

LATEST REVENUE…Verify in official filing

MATCHED NET INCOME…No normalized match

PRIMARY SOURCESECIssuer identity and filings

ANALYSIS ROUTE

Four checks before any decision

Business model

Understand how the company earns and where demand originates.

Revenue and margin

Compare equivalent periods; separate growth from profitability.

Debt and cash flow

Test balance-sheet resilience and cash conversion.

Valuation and risk

Use sector peers, scenarios and explicit risk limits.

Company calendar

Nov 4, 2026November 4 US date · after market close, exact time not announced

Myriad Genetics Q3 2026 financial results

Third-quarter results will be released after US markets close November 4. Financial performance of the molecular diagnostic testing business is in focus; the exact release minute was not announced.

Myriad Genetics ↗

Nov 5, 202600:30 Istanbul · November 4 at 4:30 PM US Eastern

Myriad Genetics Q3 2026 earnings call

Management will provide a financial overview and business update for the third quarter. The November 4 evening call in the US falls on November 5 in Istanbul.

Myriad Genetics ↗

DISCOVERY NETWORK

More NASDAQ records

Alphabetically adjacent directory records for faster navigation; this is not a peer or valuation classification.

MWYNMarwynn Holdings, Inc.NASDAQ · SEC→MXCTMaxCyte, Inc.NASDAQ · SEC→MXLMaxLinear, IncNASDAQ · SEC→MYFWFirst Western Financial, Inc.NASDAQ · SEC→MYPSPLAYSTUDIOS, Inc. NASDAQ · SEC→MYRGMYR Group, Inc.NASDAQ · SEC→MYSEMyseum.AI, Inc.NASDAQ · SEC→MYSZMy Size, Inc.NASDAQ · SEC→

DATA STATUS

Checking SEC financial statements

A dash means standardized data is unavailable. Always check the filing period, currency and accounting scope.

Open official filings ↗